NEW YORK--(BUSINESS WIRE)--Demy Colton, a leader in life sciences and digital health events, today announced that its new conference BioFuture™, an in-person and virtual event held last week in New York City, attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions, and over 60 innovative companies who shared their cutting-edge technologies and breakthrough advancements. The inaugural event was held at Cure by Deerfield, a new innovation campus, that helped make BioFuture a realization.
BioFuture’s virtual conference platform continues to be accessible to all attendees through November 30, 2021, where they can continue to engage in the following ways:
- View all recorded panels, spotlight sessions, and fireside chats
- Access pre-recorded presentations from the most innovative biotech and digital health companies
- Connect with 550+ attendees from across the world via messaging and the virtual platform
Please save the date for BioFuture 2022 - Oct. 4-6 in New York City.
This year’s program featured timely, highly relevant, inclusive and diverse sessions focused on digital therapeutics, robotics, psychedelics, digital health VC trends, next-generation oncology therapies, decentralized clinical trials and manufacturing to address COVID-19, and others. A list of all speakers is available here with many high-profile leaders, including surprise guest Deepak Chopra, who attended the event in person.
“This has been one of the most successful events we’ve launched, with significant numbers of industry participants attending in-person as well as virtually. This year’s inaugural BioFuture demonstrated that there continues to be an intense desire in our industry to network and learn from others, especially now as travel restrictions have begun to ease. ,” said Sara Jane Demy, Founder and CEO, Demy-Colton. “The overwhelmingly positive response from the audience, participants and sponsors shows us that the launch of BioFuture, a new event which converges digital health with life sciences supports Demy- Colton’s decision to focus on new events that can inspire thought and innovation across the wider healthcare industry.”
BioFuture was a valuable event for Cognito, a pioneer in disease-modifying digital therapeutics, to network and meet with potential partners, and key-decision makers in the industry, as we prepare for our pivotal study launch in Alzheimer’s Disease early next year,” said Brent Vaughan, CEO, Cognito Therapeutics.
“Our team really enjoyed attending BioFuture, and we had a lot of relevant discussions, as we prepare to commercialize our first next-generation digital therapeutic, that uses music, software and sensors to help stroke survivors and other patients suffering from neurologic injuries and diseases improve their walking function," said Brian Harris, CEO & Founder, MedRhythms.
“We’re proud to sponsor the inaugural BioFuture, which was a massive success that brought together industry leaders to discuss disruptive ideas in healthcare,” said Tim Opler, Partner and Co-Founder, Torreya. “This year’s launch is just the beginning and we look forward to supporting the Demy-Colton team in featuring BioFuture as an annual must-attend event in life sciences and digital health.”
For more information, please visit www.biofuture.com or follow us on Twitter at @Demy_Colton.
Demy-Colton is a leading life sciences and digital health events organization, at the forefront of building networks between innovative life sciences companies and industry stakeholders. Its unique events facilitate networking on a global scale, including Biotech Showcase™, BioFuture™, Biotech CEO Summit Europe™, and Biotech CEO Summit Napa™, Demy-Colton Virtual Salons, and CEO Virtual Dialogues. These events build networking communities that transcend geographical boundaries and establish ongoing, high-value relationships among the industry’s top decision makers, investors, and thought leaders, where investment, learning, and thoughtful conversations thrive. For more information, visit www.demy-colton.com.